Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Profile Treatment Approach Name | PD-L1/PD-1 antibody |
Profile Name | CD274 over exp |
Drug Class | PD-L1/PD-1 antibody 122 |
Therapy |
PubMed Id | Reference Title | Details |
---|---|---|
(35101885) | FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC. | Full reference... |
(33316104) | Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer. | Full reference... |